L-4,5,6,7-Tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid
Need Assistance?
  • US & Canada:
    +
  • UK: +

L-4,5,6,7-Tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
Bicyclic Amino Acids
Catalog number
BAT-005576
CAS number
59981-63-4
Molecular Formula
C7H9N3O2
Molecular Weight
167.17
L-4,5,6,7-Tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid
IUPAC Name
(6S)-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine-6-carboxylic acid
Synonyms
Spinacine
Appearance
White crystalline powder
Purity
≥ 98% (Titration)
Density
1.439g/cm3
Boiling Point
552.2ºC at 760 mmHg
Storage
Store at 2-8°C
InChI
InChI=1S/C7H9N3O2/c11-7(12)5-1-4-6(2-8-5)10-3-9-4/h3,5,8H,1-2H2,(H,9,10)(H,11,12)/t5-/m0/s1
InChI Key
YCFJXOFFQLPCHD-YFKPBYRVSA-N
Canonical SMILES
C1C(NCC2=C1N=CN2)C(=O)O
1. L-163,491 is a partial angiotensin AT(1) receptor agonist in the hindquarters vascular bed of the cat
B J De Witt, E A Garrison, H C Champion, P J Kadowitz Eur J Pharmacol. 2000 Sep 15;404(1-2):213-9. doi: 10.1016/s0014-2999(00)00612-9.
Responses to the nonpeptide angiotensin II agonist 5, 7-Dimethyl-2-ethyl-3-[[2'-([butyloxycarbonyl) aminosulfonyl]-5'-(3-methyoxybenzyl)-[1, 1'-biphenyl]-4-yl]methyl]-3H-imidazo[4,5-b]pyridine (L-163,491) were investigated and compared with responses to angiotensin II, angiotensin IV and norepinephrine in the hindquarters vascular bed of the cat under constant-flow conditions. Injections of L-163,491 into the hindquarter perfusion circuit caused dose-related increases in hindquarters perfusion pressure. In relative terms, angiotensin II was more potent than norepinephrine, which was more potent than angiotensin IV and L-163,491 in increasing hindlimb vascular resistance. The slope of the dose-response curve for L-163,491 was flat, while the apparent affinity of the compound for angiotensin AT(1) receptors was slightly greater than angiotensin IV. Responses to L-163,491 were inhibited by the angiotensin AT(1) receptor antagonist DuP 532 (2-propyl-4-pentafluoroethyl-1-[2'-(1H-tetrazol-5-yl)bipheny l-4-yl)me thyl]imidazole-5-carboxylic acid) and were not altered by the angiotensin AT(2) receptor antagonist PD123,319 (S(+)-1-[[4-(Dimethylamino)-3-methylphenyl]methyl]-5-(diphenylacetyl+ ++) -4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid ditribluoroacetate). However, the increase in hindlimb perfusion pressure in response to angiotensin II and angiotensin IV was significantly decreased following injection of L-163,491. These data suggest that the nonpeptide angiotensin analog L-163,491 has partial agonist activity, which is dependent on the stimulation of angiotensin AT(1) receptors in the hindquarters vascular bed of the cat.
2. Formation equilibria of nickel complexes with glycyl-histidyl-lysine and two synthetic analogues
Chiara Conato, Henryk Kozłowski, Jolanta Swiatek-Kozłowska, Piotr Młynarz, Maurizio Remelli, Sergio Silvestri J Inorg Biochem. 2004 Jan;98(1):153-60. doi: 10.1016/j.jinorgbio.2003.09.010.
Complex-formation equilibria between the Ni(II) ion and the natural tripeptide glycyl-L-histidyl-L-lysine have been investigated. Two synthetic analogues, where the histidine residue has been substituted with L-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid (L-Spinacine) and L-1,2,3,4-tetrahydro-isoquinolin-3-carboxylic acid (Tic), respectively, have been considered, as well. Different experimental techniques have been employed: potentiometry, calorimetry, visible spectrophotometry and CD spectroscopy. Structural hypotheses on the main complex species are suggested. Evidences on the formation of tetrameric species with the first ligand are shown. No involvement of the side-chain amino group of lysine residue in metal ion coordination was found.
Online Inquiry
Verification code
Inquiry Basket